NDC 64406-022 – Tofidence
Tocilizumab 20 mg/mL · Injection · Intravenous
Product NDC64406-022
Product details
- Brand name
- Tofidence
- Generic name
- Tocilizumab
- Labeler
- Biogen MA Inc
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761354
- Marketed since
- May 1, 2024
- Marketing end
- August 1, 2027
- Pharmacologic class
- Interleukin-6 Receptor Antagonist
Active ingredients
- Tocilizumab 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 64406-022-01 | 1 VIAL, SINGLE-USE in 1 CARTON (64406-022-01) / 4 mL in 1 VIAL, SINGLE-USE | May 1, 2024 |